Huntington National Bank’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.3K | Sell |
761
-86
| -10% | -$2.42K | ﹤0.01% | 1739 |
|
|
2026
Q1 | $24.2K | Sell |
847
-39
| -4% | -$1.33K | ﹤0.01% | 1587 |
|
|
2025
Q4 | $35.1K | Sell |
886
-3
| -0.3% | -$110 | ﹤0.01% | 1384 |
|
|
2025
Q3 | $31.3K | Buy |
889
+15
| +2% | +$517 | ﹤0.01% | 1443 |
|
|
2025
Q2 | $28.6K | Buy |
874
+18
| +2% | +$585 | ﹤0.01% | 1451 |
|
|
2025
Q1 | $27.6K | Sell |
856
-27
| -3% | -$1K | ﹤0.01% | 1418 |
|
|
2024
Q4 | $27K | Buy |
883
+8
| +0.9% | +$257 | ﹤0.01% | 1454 |
|
|
2024
Q3 | $24.5K | Buy |
875
+147
| +20% | +$3.62K | ﹤0.01% | 1447 |
|
|
2024
Q2 | $16.6K | Buy |
728
+301
| +70% | +$6.95K | ﹤0.01% | 1520 |
|
|
2024
Q1 | $13K | Sell |
427
-46
| -10% | -$1.54K | ﹤0.01% | 1607 |
|
|
2023
Q4 | $16.9K | Buy |
473
+32
| +7% | +$1.19K | ﹤0.01% | 1474 |
|
|
2023
Q3 | $19.3K | Sell |
441
-12
| -3% | -$585 | ﹤0.01% | 1360 |
|
|
2023
Q2 | $22.4K | Buy |
453
+63
| +16% | +$2.9K | ﹤0.01% | 1324 |
|
|
2023
Q1 | $16.2K | Buy |
390
+15
| +4% | +$622 | ﹤0.01% | 1403 |
|
|
2022
Q4 | $16.6K | Sell |
375
-27
| -7% | -$1.13K | ﹤0.01% | 1348 |
|
|
2022
Q3 | $16K | Hold |
402
| – | – | ﹤0.01% | 1364 |
|
|
2022
Q2 | $16K | Sell |
402
-49
| -11% | -$2.32K | ﹤0.01% | 1407 |
|
|
2022
Q1 | $30K | Buy |
451
+399
| +767% | +$25.9K | ﹤0.01% | 1230 |
|
|
2021
Q4 | $4K | Buy |
52
+36
| +225% | +$2.62K | ﹤0.01% | 1757 |
|
|
2021
Q3 | $1K | Buy |
+16
| New | +$1.23K | ﹤0.01% | 1719 |
|
|
2019
Q3 | – | Sell |
-300
| Closed | -$9K | – | 1516 |
|
|
2019
Q2 | $9K | Hold |
300
| – | – | ﹤0.01% | 1324 |
|
|
2019
Q1 | $8K | Hold |
300
| – | – | ﹤0.01% | 1308 |
|
|
2018
Q4 | $9K | Buy |
+300
| New | +$9.35K | ﹤0.01% | 1311 |
|
|
2016
Q2 | – | Sell |
-103
| Closed | -$2K | – | 1502 |
|
|
2016
Q1 | $2K | Buy |
103
+37
| +56% | +$651 | ﹤0.01% | 1637 |
|
|
2015
Q4 | $1K | Sell |
66
-18
| -21% | -$371 | ﹤0.01% | 1605 |
|
|
2015
Q3 | $2K | Sell |
84
-18
| -18% | -$450 | ﹤0.01% | 1621 |
|
|
2015
Q2 | $3K | Sell |
102
-1
| -1% | -$22 | ﹤0.01% | 1652 |
|
|
2015
Q1 | $2K | Buy |
103
+13
| +14% | +$252 | ﹤0.01% | 1648 |
|
|
2014
Q4 | $2K | Buy |
+90
| New | +$1.54K | ﹤0.01% | 1628 |
|
Other funds holding ATRC
Huntington National Bank's ATRC Position: Q2 2026 in Review
Huntington National Bank reduced its AtriCure (ATRC) stake by 10% in Q2 2026, selling an estimated $2.42K and leaving 761 shares worth $21.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1739.
Huntington National Bank first reported a position in ATRC in Q4 2014 and has held it in 29 quarters since. The position peaked at $35.1K in Q4 2025. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Huntington National Bank held 761 shares of AtriCure worth $21.3K as of Q2 2026.
- Huntington National Bank sold 86 AtriCure shares in Q2 2026, an estimated $2.42K.
- AtriCure made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #1739 holding.
- Huntington National Bank first reported a position in AtriCure in Q4 2014 and has held it in 29 quarters since.
- Huntington National Bank's AtriCure position peaked at $35.1K in Q4 2025.
- 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.